DAG1 and acute myeloid leukemia: There is one study suggesting diminished expression of the transmembrane glycoprotein complex dystroglycan along with altered mRNA expression of enzymes involved in dystroglycan glycosylation, including POMGnT1 and POMT2 in myeloid blasts from AML patients [66].